Menu
The grades of four Pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating. More
2013 has been a very good year for some high-profile companies. In fact, for a few of these stocks, this year has been a little too good. More
Try at-the-money call options on strong names in the pharmaceutical sector. More
Four Pharmaceutical stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy"). More
markets managed to start out the new month on a up note, as pharmaceuticals and technology companies shined during a broad-based rally More
This week, four Pharmaceutical stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More
Sponsored By:
Sponsored By:
